C’mon ladies! Now we have to endure the horrible commercials like the ones for Viagra or Cialis. “When the time is right”…

WASHINGTON (AP) — The drug industry’s decade-spanning search for a female equivalent to Viagra took a major step forward Thursday, as government experts recommended approval for a pill to boost sexual desire in women.

Trending: JUST IN: President Trump Owns Argumentative Leslie Stahl: “I’m President…and you’re not.” [Video]

The first-of-a-kind endorsement came with safety reservations, however, due to drug side effects including fatigue, low blood pressure and fainting

take our poll - story continues below

Who should replace Nikki Haley as our ambassador to the U.N.?

  • Who should replace Nikki Haley as our ambassador to the U.N.?  

  • This field is for validation purposes and should be left unchanged.
Completing this poll grants you access to 100PercentFedUp.com updates free of charge. You may opt out at anytime. You also agree to this site's Privacy Policy and Terms of Use.

The panel of Food and Drug Administration advisers voted 18-6 in favor of Sprout Pharmaceutical’s daily pill, flibanserin, on the condition that the company develops a plan to manage its risks.

The recommendation is a major victory for a drug sometimes hailed as “female Viagra,” but which has been plagued for years by concerns of lackluster effectiveness and safety issues. The FDA has rejected the drug twice since 2010. And a similar panel of FDA experts voted unanimously against the drug five years ago.

Thursday’s vote is non-binding but the FDA often follows the advice of its experts. An official decision is expected in August.

FDA’s experts acknowledged that flibanserin’s effect is not very strong, but said there is a need for FDA-approved drugs to address female sexual problems.

“These are very modest results,” said Dr. Julia Heiman of the Kinsey Institute at Indiana University. “But on the other hand, even modest results can make a lot of difference when you’re at a certain point in the clinical problem.”

Via: Breitbart


Join The Conversation. Leave a Comment.